424 related articles for article (PubMed ID: 28234047)
21. An Alpha-1 Antitrypsin Deficiency Screening Study in Patients with Chronic Obstructive Pulmonary Disease, Bronchiectasis, or Asthma in Turkey.
Tural Onur S; Natoli A; Dreger B; Arınç S; Sarıoğlu N; Çörtük M; Karadoğan D; Şenyiğit A; Yıldız BP; Köktürk N; Argun Barıs S; Kodalak Cengiz S; Polatli M
Int J Chron Obstruct Pulmon Dis; 2023; 18():2785-2794. PubMed ID: 38046982
[TBL] [Abstract][Full Text] [Related]
22. Pathophysiology of Alpha-1 Antitrypsin Lung Disease.
Kalfopoulos M; Wetmore K; ElMallah MK
Methods Mol Biol; 2017; 1639():9-19. PubMed ID: 28752442
[TBL] [Abstract][Full Text] [Related]
23. Alpha-1 Antitrypsin Deficiency in COPD Patients: A Cross-Sectional Study.
Sorroche PB; Fernández Acquier M; López Jove O; Giugno E; Pace S; Livellara B; Legal S; Oyhamburu J; Saez MS
Arch Bronconeumol; 2015 Nov; 51(11):539-43. PubMed ID: 25800328
[TBL] [Abstract][Full Text] [Related]
24. Alpha-1 antitrypsin deficiency: new developments in augmentation and other therapies.
Turner AM
BioDrugs; 2013 Dec; 27(6):547-58. PubMed ID: 23771682
[TBL] [Abstract][Full Text] [Related]
25. Small airways disease in patients with alpha-1 antitrypsin deficiency.
Toumpanakis D; Usmani OS
Respir Med; 2023 May; 211():107222. PubMed ID: 36965591
[TBL] [Abstract][Full Text] [Related]
26. Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting.
Bull World Health Organ; 1997; 75(5):397-415. PubMed ID: 9447774
[TBL] [Abstract][Full Text] [Related]
27. The national alpha-1 antitrypsin deficiency registry in Poland.
Chorostowska-Wynimko J; Struniawski R; Sliwinski P; Wajda B; Czajkowska-Malinowska M
COPD; 2015 May; 12 Suppl 1():22-6. PubMed ID: 25938287
[TBL] [Abstract][Full Text] [Related]
28. A review of augmentation therapy for alpha-1 antitrypsin deficiency.
Mohanka M; Khemasuwan D; Stoller JK
Expert Opin Biol Ther; 2012 Jun; 12(6):685-700. PubMed ID: 22500781
[TBL] [Abstract][Full Text] [Related]
29. Hereditary alpha-1-antitrypsin deficiency and its clinical consequences.
Fregonese L; Stolk J
Orphanet J Rare Dis; 2008 Jun; 3():16. PubMed ID: 18565211
[TBL] [Abstract][Full Text] [Related]
30. Alpha-1 Antitrypsin Augmentation Inhibits Proteolysis of Neutrophil Membrane Voltage-Gated Proton Channel-1 in Alpha-1 Deficient Individuals.
Hawkins P; Sya J; Hup NK; Murphy MP; McElvaney NG; Reeves EP
Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441020
[No Abstract] [Full Text] [Related]
31. alpha1-Antitrypsin deficiency: best clinical practice.
Kalsheker NA
J Clin Pathol; 2009 Oct; 62(10):865-9. PubMed ID: 19783716
[TBL] [Abstract][Full Text] [Related]
32. Augmentation Therapy for Severe Alpha-1 Antitrypsin Deficiency Improves Survival and Is Decoupled from Spirometric Decline-A Multinational Registry Analysis.
Fraughen DD; Ghosh AJ; Hobbs BD; Funk GC; Meischl T; Clarenbach CF; Sievi NA; Schmid-Scherzer K; McElvaney OJ; Murphy MP; Roche AD; Clarke L; Strand M; Vafai-Tabrizi F; Kelly G; Gunaratnam C; Carroll TP; McElvaney NG
Am J Respir Crit Care Med; 2023 Nov; 208(9):964-974. PubMed ID: 37624745
[No Abstract] [Full Text] [Related]
33. A review of α1-antitrypsin deficiency.
Stoller JK; Aboussouan LS
Am J Respir Crit Care Med; 2012 Feb; 185(3):246-59. PubMed ID: 21960536
[TBL] [Abstract][Full Text] [Related]
34. [Molecular diagnostics of alpha-1-antitrypsin deficiency in clinical practice].
Struniawski R; Szpechciński A; Chorostowska-Wynimko J
Pneumonol Alergol Pol; 2008; 76(4):253-64. PubMed ID: 18785130
[TBL] [Abstract][Full Text] [Related]
35. State-of-the-art testing for alpha-1 antitrypsin deficiency.
Kueppers F; Sanders C
Allergy Asthma Proc; 2017 Mar; 38(2):108-114. PubMed ID: 28120746
[TBL] [Abstract][Full Text] [Related]
36. Emphysema in alpha1-antitrypsin deficiency: does replacement therapy affect outcome?
Abboud RT; Ford GT; Chapman KR
Treat Respir Med; 2005; 4(1):1-8. PubMed ID: 15725045
[TBL] [Abstract][Full Text] [Related]
37. Alpha-1 antitrypsin augmentation therapy.
Wewers MD; Crystal RG
COPD; 2013 Mar; 10 Suppl 1():64-7. PubMed ID: 23527997
[TBL] [Abstract][Full Text] [Related]
38. New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin Deficiency.
Chorostowska-Wynimko J; Barrecheguren M; Ferrarotti I; Greulich T; Sandhaus RA; Campos M
Int J Chron Obstruct Pulmon Dis; 2020; 15():345-355. PubMed ID: 32103933
[TBL] [Abstract][Full Text] [Related]
39. Alpha-1 antitrypsin augmentation therapy and biomarkers of elastin degradation.
Ma S; Lin YY; He J; Rouhani FN; Brantly M; Turino GM
COPD; 2013 Aug; 10(4):473-81. PubMed ID: 23560990
[TBL] [Abstract][Full Text] [Related]
40. Aralast: an alpha 1-protease inhibitor for the treatment of alpha-antitrypsin deficiency.
Mordwinkin NM; Louie SG
Expert Opin Pharmacother; 2007 Oct; 8(15):2609-14. PubMed ID: 17931094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
